These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 15511459)

  • 1. Pediatric cardiac transplantation in children with high panel reactive antibody.
    Jacobs JP; Quintessenza JA; Boucek RJ; Morell VO; Botero LM; Badhwar V; van Gelder HM; Asante-Korang A; McCormack J; Daicoff GR
    Ann Thorac Surg; 2004 Nov; 78(5):1703-9. PubMed ID: 15511459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of cardiac transplantation in highly sensitized pediatric patients.
    Scott V; Williams RJ; Levi DS
    Pediatr Cardiol; 2011 Jun; 32(5):615-20. PubMed ID: 21380717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of children undergoing cardiac transplantation with high Panel Reactive Antibodies.
    Asante-Korang A; Jacobs JP; Ringewald J; Carapellucci J; Rosenberg K; McKenna D; McCormack J; Wilmot I; Gjeldum A; Lopez-Cepero M; Sleasman J
    Cardiol Young; 2011 Dec; 21 Suppl 2():124-32. PubMed ID: 22152539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of a negative conversion trial and subsequent living donor kidney transplant outcome in recipients with a positive lymphocyte crossmatch.
    Huh KH; Kim SI; Joo DJ; Ju MK; Chang HK; Kim HJ; Kim YS; Kim MS
    Nephron Clin Pract; 2009; 111(1):c49-54. PubMed ID: 19052470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly Sensitized Patients: Miami Transplant Institute Experience.
    Mattiazzi AD; Centeno A; Amador A; Fernandez-Bango C; Scowby CD; O'Rourke M; Hill-Matthie T; Patel R; Barrios F; Ruiz P; Chen L; Saghesima J; Ciancio G; Burke GW; Goldstein M; Chandar J; Contreras G; Roth D; Kupin W; Guerra G; Vianna R
    Clin Transpl; 2014; ():171-8. PubMed ID: 26281142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Panel-reactive antibody levels and renal transplantation rates in sensitized patients after desensitization and human leucocyte antigen amino acid residue matching.
    Shang W; Dong L; Feng G; Wang Y; Pang X; Li J; Liu L; Zhang W
    J Int Med Res; 2013 Aug; 41(4):1333-41. PubMed ID: 23780877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac transplantation in pediatric patients: fifteen-year experience of a single center.
    Groetzner J; Reichart B; Roemer U; Reichel S; Kozlik-Feldmann R; Tiete A; Sachweh J; Netz H; Daebritz S
    Ann Thorac Surg; 2005 Jan; 79(1):53-60; discussion 61. PubMed ID: 15620914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes in highly sensitized pediatric heart transplant patients using current management strategies.
    Asante-Korang A; Amankwah EK; Lopez-Cepero M; Ringewald J; Carapellucci J; Krasnopero D; Berg A; Quintessenza J; Jacobs JP
    J Heart Lung Transplant; 2015 Feb; 34(2):175-81. PubMed ID: 25447583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric cardiac transplantation. The Stanford experience.
    Sarris GE; Smith JA; Bernstein D; Griffin ML; Pitlick PT; Baum D; Billingham ME; Oyer PE; Stinson EB; Starnes VA
    Circulation; 1994 Nov; 90(5 Pt 2):II51-5. PubMed ID: 7955282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rescue cardiac transplantation for failing staged palliation in patients with hypoplastic left heart syndrome.
    Jacobs JP; Quintessenza JA; Chai PJ; Lindberg HL; Asante-Korang A; McCormack J; Dadlani G; Boucek RJ
    Cardiol Young; 2006 Dec; 16(6):556-62. PubMed ID: 17116269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality and morbidity in pre-sensitized pediatric heart transplant recipients with a positive donor crossmatch utilizing peri-operative plasmapheresis and cytolytic therapy.
    Holt DB; Lublin DM; Phelan DL; Boslaugh SE; Gandhi SK; Huddleston CB; Saffitz JE; Canter CE
    J Heart Lung Transplant; 2007 Sep; 26(9):876-82. PubMed ID: 17845925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased incidence of acute rejection in adolescent kidney transplant recipients using antithymocyte induction and triple immunosuppression.
    Schwartz JJ; Ishitani MB; Weckwerth J; Morgenstern B; Milliner D; Stegall MD
    Transplantation; 2007 Sep; 84(6):715-21. PubMed ID: 17893604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmapheresis with intravenous immunoglobulin G is effective in patients with elevated panel reactive antibody prior to cardiac transplantation.
    Pisani BA; Mullen GM; Malinowska K; Lawless CE; Mendez J; Silver MA; Radvany R; Robinson JA
    J Heart Lung Transplant; 1999 Jul; 18(7):701-6. PubMed ID: 10452347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-T-cell-antibody prophylaxis in children: success with a novel combination strategy of mycophenolate mofetil and antithymocyte serum.
    Boucek MM; Pietra B; Sondheimer H; Luna M; Shaffer E; Hall P; Campbell D
    Transplant Proc; 1997 Dec; 29(8A):16S-20S. PubMed ID: 9414669
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of mycophenolate mofetil in heart transplantation.
    Mathieu P; Carrier M; White M; Pellerin M; Perrault L; Pelletier G; Robitaille D; Pelletier LC
    Can J Surg; 2000 Jun; 43(3):202-6. PubMed ID: 10851414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplantation of high panel-reactive antibody left ventricular assist device patients without crossmatch using on-bypass pheresis and alemtuzumab.
    Lick SD; Beckles DL; Piovesana G; Vaidya S; Indrikovs A; Barbagelata NA; Valentine V
    Ann Thorac Surg; 2011 Oct; 92(4):1428-34. PubMed ID: 21855854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allosensitization and outcomes in pediatric heart transplantation.
    Mahle WT; Tresler MA; Edens RE; Rusconi P; George JF; Naftel DC; Shaddy RE;
    J Heart Lung Transplant; 2011 Nov; 30(11):1221-7. PubMed ID: 21821435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart transplantation in children with congenital heart disease.
    Hsu DT; Quaegebeur JM; Michler RE; Smith CR; Rose EA; Kichuk MR; Gersony WM; Douglas JF; Addonizio LJ
    J Am Coll Cardiol; 1995 Sep; 26(3):743-9. PubMed ID: 7642869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desensitization and renal transplant: plasmapheresis/IVIG standard dose in patients with high immunological risk.
    Flores-Gama F; Mondragón-Ramírez GA; Bochicchio-Riccardelli T
    Cir Cir; 2009; 77(5):369-74. PubMed ID: 19944025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.